Comparative evaluation of disk diffusion with microdilution assay in susceptibility testing of caspofungin against Aspergillus and Fusarium isolates

被引:41
作者
Arikan, S [1 ]
Paetznick, V [1 ]
Rex, JH [1 ]
机构
[1] Univ Texas, Sch Med, Dept Internal Med,Div Infect Dis, Ctr Study Emerging & Reemerging Pathogens, Houston, TX 77030 USA
关键词
D O I
10.1128/AAC.46.9.3084-3087.2002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We compared the disk diffusion and broth microdilution methods for susceptibility testing of caspofungin against Aspergillus (n = 78) and Fusarium (n = 22) isolates. Microdilution testing followed the NCCLS M-38P guidelines but was performed in antibiotic medium 3 supplemented to 2% glucose (AM3). Disk diffusion assays were performed on AM3 agar plates with a 2-mug caspofungin disk. By both methods, caspofungin showed favorable activity against Aspergillus isolates and no activity against Fusarium isolates. In the disk-based format, intrazonal growth that was not influenced by the drug concentration gradient was consistently observed for all of the Aspergillus isolates tested.
引用
收藏
页码:3084 / 3087
页数:4
相关论文
共 22 条
  • [1] In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates
    Arikan, S
    Lozano-Chiu, M
    Paetznick, V
    Rex, JH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (01) : 327 - 330
  • [2] ARIKAN S, 2000, EMERGING DRUGS, V5, P135
  • [3] IN-VITRO EVALUATION OF THE PNEUMOCANDIN ANTIFUNGAL AGENT L-733560, A NEW WATER-SOLUBLE HYBRID OF L-705589 AND L-731373
    BARTIZAL, K
    SCOTT, T
    ABRUZZO, GK
    GILL, CJ
    PACHOLOK, C
    LYNCH, L
    KROPP, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (05) : 1070 - 1076
  • [4] Membrane and cell wall targets in Aspergillus fumigatus
    Beauvais, A
    Latgé, JP
    [J]. DRUG RESISTANCE UPDATES, 2001, 4 (01) : 38 - 49
  • [5] Susceptibility of fluconazole-resistant clinical isolates of Candida spp. to echinocandin LY303366, itraconazole and amphotericin B
    Cuenca-Estrella, M
    Mellado, E
    Díaz-Guerra, TM
    Monzón, A
    Rodríguez-Tudela, JL
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (03) : 475 - 477
  • [6] In vitro antifungal activity of pneumocandin L-743,872 against a variety of clinically important molds
    DelPoeta, M
    Schell, WA
    Perfect, JR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (08) : 1835 - 1836
  • [7] Echinocandins and pneumocandins - a new antifungal class with a novel mode of action
    Denning, DW
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (05) : 611 - 614
  • [8] Update on antifungals targeted to the cell wall:: focus on β-1,3-glucan synthase inhibitors
    Georgopapadakou, NH
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2001, 10 (02) : 269 - 280
  • [9] Correlation between antifungal susceptibilities of Coccidioides immitis in vitro and antifungal treatment with caspofungin in a mouse model
    González, GM
    Tijerina, R
    Najvar, LK
    Bocanegra, R
    Luther, M
    Rinaldi, MG
    Graybill, JR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (06) : 1854 - 1859
  • [10] Graybill J R, 2001, Curr Opin Investig Drugs, V2, P468